The case of an infant thought to have an extremely rare form of porphyria, called harderoporphyria (HARPO), was described…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The seven-day Porphyria Awareness Week campaign kicks off May 12 to spread the word about porphyria and culminates with…
People with acute intermittent porphyria (AIP) often consume large amounts of simple sugars and fats, which may contribute to…
A boy’s long medical odyssey, which eventually led to a diagnosis of congenital erythropoietic porphyria (CEP) but left the…
The production of bile acids, which are molecules made by the liver to help with digestion, is dysregulated in people…
By combing through a database from the U.S. Food and Drug Administration (FDA), scientists in China have compiled a list…
The human immunodeficiency virus (HIV) was the trigger for porphyria cutanea tarda, a condition characterized by painful, blistering skin…
For this year’s Global Porphyria Day on May 18, supporters are encouraged to wear purple, decorate their homes in purple,…
A wearable light sensor may be used to help track light exposure and predict the risk of symptoms for people…
The Phase 2 AURORA clinical trial has met its main goal, demonstrating that treatment with the experimental oral medication bitopertin…